AstraZeneca opens $360m drug manufacturing facility in Dublin as Ireland bets on pharma resilience
AstraZeneca has inaugurated a $360 million active pharmaceutical ingredient manufacturing facility in Dublin, in a move that reinforces Ireland’s position as a critical node in the Anglo-Swedish drugmaker’s global...

